AC Immune SA (ACIU)
3.00
+0.16
(+5.63%)
USD |
NASDAQ |
Nov 01, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
AC Immune Price to Book Value: 2.162 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.162 |
| October 31, 2024 | 2.046 |
| October 30, 2024 | 2.140 |
| October 29, 2024 | 2.169 |
| October 28, 2024 | 2.162 |
| October 25, 2024 | 2.198 |
| October 24, 2024 | 2.162 |
| October 23, 2024 | 2.191 |
| October 22, 2024 | 2.241 |
| October 21, 2024 | 2.212 |
| October 18, 2024 | 2.256 |
| October 17, 2024 | 2.313 |
| October 16, 2024 | 2.299 |
| October 15, 2024 | 2.306 |
| October 14, 2024 | 2.299 |
| October 11, 2024 | 2.392 |
| October 10, 2024 | 2.407 |
| October 09, 2024 | 2.443 |
| October 08, 2024 | 2.385 |
| October 07, 2024 | 2.450 |
| October 04, 2024 | 2.436 |
| October 03, 2024 | 2.443 |
| October 02, 2024 | 2.508 |
| October 01, 2024 | 2.702 |
| September 30, 2024 | 2.724 |
| Date | Value |
|---|---|
| September 27, 2024 | 2.702 |
| September 26, 2024 | 2.666 |
| September 25, 2024 | 2.659 |
| September 24, 2024 | 2.681 |
| September 23, 2024 | 2.637 |
| September 20, 2024 | 2.659 |
| September 19, 2024 | 2.659 |
| September 18, 2024 | 2.616 |
| September 17, 2024 | 2.493 |
| September 16, 2024 | 2.356 |
| September 13, 2024 | 2.292 |
| September 12, 2024 | 2.198 |
| September 11, 2024 | 2.205 |
| September 10, 2024 | 2.220 |
| September 09, 2024 | 2.198 |
| September 06, 2024 | 2.155 |
| September 05, 2024 | 2.241 |
| September 04, 2024 | 2.248 |
| September 03, 2024 | 2.205 |
| August 30, 2024 | 2.328 |
| August 29, 2024 | 2.328 |
| August 28, 2024 | 2.263 |
| August 27, 2024 | 2.205 |
| August 26, 2024 | 2.277 |
| August 23, 2024 | 2.220 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7361
Minimum
Dec 22 2022
3.597
Maximum
Dec 29 2023
1.785
Average
1.765
Median
Price to Book Value Benchmarks
| CRISPR Therapeutics AG | 2.182 |
| Addex Therapeutics Ltd | 0.8125 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.174 |
| MoonLake Immunotherapeutics | 5.648 |
Price to Book Value Related Metrics
| Price to Free Cash Flow | 5.768 |
| Price | 3.00 |
| Earnings Yield | -24.02% |
| Market Cap | 296.82M |